|
"navarra s"的相關文件
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-03-10T08:55:54Z |
Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women
|
Kung A.W.-C.; Rachman I.A.; Adam J.M.F.; Roeshadi D.; Torralba T.; Navarra S.; Gamilla Z.; Ca?ete A.; de la Rosa M.; KEH-SUNG TSAI; Lin H.-Y.; Soong Y.K.; Lan J.-L.; Hsu H.-C.; Tu S.-T.; Lin R.-M.; Yuktanandana P.; Songpatanasilp T.; Ngarmukos S.; Soontrapa S.; Soontrapa S.; Rojanasthien S.; Luevitoonvechkij S.; Leerapan T.; Albert A.; Vanbelle S. |
| 中山醫學大學 |
2021 |
Year-3 Observational Follow-up of Belimumab Safety (Mortality and Malignancies) in Patients with SLE Who Completed a Phase 4, 52-Week, Randomized, Double-Blind Placebo-Controlled Safety Study
|
Sheikh, S; Wei, CC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Kurrasch, R; Fernandes, S; Harris, J; Muzaffar, S; Fox, NL; Liu, A; Quasny, H; Roth, D |
| 中山醫學大學 |
2021 |
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
|
Sheikh, SZ; Scheinberg, MA; Wei, JCC; Tegzova, D; Stohl, W; de Toledo, RA; Mucenic, T; Banfi, MRA; Maksimowicz-McKinnon, K; Abud-Mendoza, C; Navarra, S; Garcia, M; Garcia-De La Torre, I; Ros, JO; Levy, RA; Bass, DL; Terres, JR; Punwaney, R; Harris, J; Nami, A; Pierce, A; Thorneloe, KS; Ji, B; Roth, DA |
| 國立成功大學 |
2013-06 |
DEMOGRAPHICS, ORGAN INVOLVEMENT AND MEDICATIONS IN SLE PATIENTS FROM SIX COUNTRIES IN ASIA-PACIFIC
|
Jakes, R. W.; Navarra, S.; Jain, P.; Louthrenoo, W.; Bae, S. -C.; Hoi, A.; Kong, N. C. T.; Koolvisoot, A.; Lin, H. -Y.; Nash, P.; Weng, M. -Y. |
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
|
